GlassScriptPhysician profile
Peter Stanford Kirk
NPI 1053817692
$1,190.19
in general payments reported to CMS, 2019-2025
19 companies · $976 in 2025
The $976 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $214 · 2025: $976.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,190.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,190.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $141.78 | 2024-2025 | |
| Janssen Biotech, INC. | $128.10 | 2024-2025 | Erleada, Akeega, Balversa |
| Procept Biorobotics Corporation | $117.58 | 2025 | |
| Verity Pharmaceuticals INC. | $104.14 | 2025 | Tlando, Trelstar |
| Ferring Pharmaceuticals INC. | $102.49 | 2025 | Adstiladrin |
| Astellas Pharma US INC | $89.68 | 2024-2025 | Xtandi |
| Sun Pharmaceutical Industries INC. | $80.07 | 2024-2025 | |
| Urogen Pharma, INC. | $70.92 | 2025 | |
| Pfizer INC. | $57.78 | 2025 | |
| Dendreon Pharmaceuticals LLC | $57.07 | 2025 | Provenge |
| Bluewind Medical | $48.94 | 2025 | Revi |
| Sumitomo Pharma America, INC. | $37.31 | 2025 | Gemtesa |
| Accord Healthcare, INC. | $30.15 | 2025 | |
| Progenics Pharmaceuticals, INC. | $26.60 | 2025 | |
| Endo USA, INC. | $24.46 | 2024 | Xiaflex, Aveed |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $20.03 | 2025 | Urolift |
| Myriad Genetic Laboratories, INC. | $20.02 | 2024 | Prolaris |
| Conmed Corporation | $18.27 | 2025 | Airseal |
| Boston Scientific Corporation | $14.80 | 2025 | Axonics |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Kirk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.